BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

532039

ZENOTECH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ZENOTECH LABORATORIES LTD. Share Price Update

As of the latest trading session, ZENOTECH LABORATORIES LTD. share price is currently at ₹ 51.1, which is down by ₹ -2.39 from its previous closing. Today, the stock has fluctuated between ₹ 49.50 and ₹ 51.30. Over the past year, ZENOTECH LABORATORIES LTD. has achieved a return of -34.82 %. In the last month alone, the return has been 1.88 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ZENOTECH LABORATORIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    311.70

  • P/E Ratio (TTM)

    62.20

  • Beta

    0.48

  • Book Value / share

    15.75

  • Return on equity

    1.66%

  • EPS (TTM)

    0.68

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -0.84

info icon alternate text

ZENOTECH LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 10.23
Operating Expense 10.73
Net Profit -0.84
Net Profit Margin (%) -8.21
Earnings Per Share (EPS) -0.14
EBITDA 3.04
Effective Tax Rate (%) 165.87
Particulars JUN 2025 (Values in Cr)
Revenue 8.64
Operating Expense 8.95
Net Profit 0.99
Net Profit Margin (%) 11.45
Earnings Per Share (EPS) 0.16
EBITDA 3.05
Effective Tax Rate (%) 22.65
Particulars MAR 2025 (Values in Cr)
Revenue 11.11
Operating Expense 9.39
Net Profit 1.23
Net Profit Margin (%) 11.07
Earnings Per Share (EPS) 0.20
EBITDA 4.92
Effective Tax Rate (%) 61.44
Particulars DEC 2024 (Values in Cr)
Revenue 10.22
Operating Expense 9.13
Net Profit 1.69
Net Profit Margin (%) 16.53
Earnings Per Share (EPS) 0.28
EBITDA 4.87
Effective Tax Rate (%) 45.65
Particulars SEP 2024 (Values in Cr)
Revenue 8.75
Operating Expense 9.11
Net Profit 1.35
Net Profit Margin (%) 15.42
Earnings Per Share (EPS) 0.22
EBITDA 4.10
Effective Tax Rate (%) 42.55
Particulars MAR 2025 (Values in Cr)
Revenue 38.98
Operating Expense 35.83
Net Profit 5.61
Net Profit Margin (%) 14.39
Earnings Per Share (EPS) 0.92
EBITDA 17.65
Effective Tax Rate (%) 47.52
Particulars MAR 2024 (Values in Cr)
Revenue 36.76
Operating Expense 30.70
Net Profit 8.30
Net Profit Margin (%) 22.57
Earnings Per Share (EPS) 1.36
EBITDA 18.23
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 38.35
Operating Expense 29.00
Net Profit 11.59
Net Profit Margin (%) 30.22
Earnings Per Share (EPS) 1.90
EBITDA 21.78
Effective Tax Rate (%) 20.13
Particulars MAR 2022 (Values in Cr)
Revenue 32.49
Operating Expense 27.29
Net Profit 22.18
Net Profit Margin (%) 68.26
Earnings Per Share (EPS) 3.63
EBITDA 18.09
Effective Tax Rate (%) -123.93
Particulars MAR 2021 (Values in Cr)
Revenue 19.37
Operating Expense 24.07
Net Profit -1.22
Net Profit Margin (%) -6.29
Earnings Per Share (EPS) -0.20
EBITDA 6.79
Effective Tax Rate (%) 0.00
Particulars MAR 2010 (Values in Cr)
Book Value / Share 28.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin -105.78
Particulars MAR 2009 (Values in Cr)
Book Value / Share 31.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.15
EBITDA Margin -198.17
Particulars MAR 2008 (Values in Cr)
Book Value / Share 36.79
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.30
EBITDA Margin -89.96
Particulars MAR 2007 (Values in Cr)
Book Value / Share 18.80
ROE % 3.92
ROCE % 1.59
Total Debt to Total Equity 0.77
EBITDA Margin 22.66
Particulars MAR 2006 (Values in Cr)
Book Value / Share 13.61
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.97
EBITDA Margin -18.41
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.75
ROE % 1.66
ROCE % 3.21
Total Debt to Total Equity 0.00
EBITDA Margin 36.54
Particulars MAR 2024 (Values in Cr)
Book Value / Share 14.84
ROE % 3.07
ROCE % 4.09
Total Debt to Total Equity 0.00
EBITDA Margin 44.65
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.48
ROE % 4.28
ROCE % 5.31
Total Debt to Total Equity 0.04
EBITDA Margin 51.37
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.57
ROE % 13.91
ROCE % 6.37
Total Debt to Total Equity 0.22
EBITDA Margin 49.47
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.43
EBITDA Margin 30.24
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 26.70
Total Assets 111.03
Total Liabilities 111.03
Total Equity 96.13
Share Outstanding 61030568
Price to Book Ratio 3.30
Return on Assets (%) 5.05
Return on Capital (%) 5.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 19.68
Total Assets 106.20
Total Liabilities 106.20
Total Equity 90.54
Share Outstanding 61030568
Price to Book Ratio 3.98
Return on Assets (%) 7.81
Return on Capital (%) 9.17
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.14
Total Assets 100.87
Total Liabilities 100.87
Total Equity 82.27
Share Outstanding 61030568
Price to Book Ratio 3.49
Return on Assets (%) 11.48
Return on Capital (%) 14.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.41
Total Assets 94.08
Total Liabilities 94.08
Total Equity 70.64
Share Outstanding 61030568
Price to Book Ratio 4.35
Return on Assets (%) 23.57
Return on Capital (%) 28.94
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.45
Total Assets 85.84
Total Liabilities 85.84
Total Equity 48.40
Share Outstanding 61030568
Price to Book Ratio 4.41
Return on Assets (%) -1.41
Return on Capital (%) -1.76
Particulars MAR 2025 (Values in Cr)
Net Income 10.69
Cash from Operations 11.42
Cash from Investing 15.28
Cash from Financing 0.00
Net change in Cash 24.77
Free Cash Flow 15.29
Particulars MAR 2024 (Values in Cr)
Net Income 11.14
Cash from Operations 12.89
Cash from Investing -21.15
Cash from Financing 0.00
Net change in Cash -9.33
Free Cash Flow 17.12
Particulars MAR 2023 (Values in Cr)
Net Income 14.50
Cash from Operations 21.85
Cash from Investing -5.82
Cash from Financing -6.11
Net change in Cash 8.72
Free Cash Flow 28.08
Particulars MAR 2022 (Values in Cr)
Net Income 9.90
Cash from Operations 18.67
Cash from Investing -1.83
Cash from Financing -15.87
Net change in Cash -0.04
Free Cash Flow 20.60
Particulars MAR 2021 (Values in Cr)
Net Income -1.21
Cash from Operations 5.85
Cash from Investing -4.81
Cash from Financing 0.45
Net change in Cash 1.37
Free Cash Flow 10.76
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 13.29 1.78 249.44 30.00 / 68.00
BLISS GVS PHARMA LTD 156.60 15.52 1.57 1654.47 105.05 / 190.65
CIPLA LTD 1501.65 22.29 3.68 121298.96 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 275.65 7.76 2.23 811.27 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2624.25 46.95 22.78 44456.38 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 17.69 5.14 249.44 30.00 / 68.00
AMRUTAJAN HEALTH LTD 724.70 38.43 6.41 2095.15 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9535.45 112.73 30.94 23838.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 156.60 23.44 1.56 1654.47 105.05 / 190.65

ZENOTECH LABORATORIES LTD. shareholding pattern

Holding

Others
31.15%
Promoter Holdings
68.84%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sun Pharmaceutical Industries Limited 4.2014578E7 (68.84%) Shareholding of Promoter and Promoter Group
Padmasree Chigurupati 3209982.0 (5.26%) Public Shareholding
Pat Financial Consultants Private Limited 2426000.0 (3.98%) Public Shareholding
Dr. Jayaram Chigurupati 2192632.0 (3.59%) Public Shareholding
Minal Bharat Patel 1050746.0 (1.72%) Public Shareholding
Zenotech Llc 692791.0 (1.14%) Public Shareholding

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

ZENOTECH LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
51.08 -4.50 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 52.40
  • 26 Days 51.80
  • 10 Days 51.70
  • 50 Days 53.20
  • 12 Days 51.60
  • 100 Days 55.60
  • 20 Days 51.60
  • 200 Days 58.90
53.59 PIVOT

First Support

53.04

First Resistance

54.04

Second Support

52.59

Second Resistance

54.59

Third Support

52.04

Third Resistance

55.04

RSI

59.65

ADX

49.67

MACD

-0.24

Williams % R

-10.59

Commodity Channel Index (CCI)

150.07

Date

2025-10-31

Week

9810.00

Same Day

8805.00

Month

8468.00

1 Year

0.49

3 Year

0.76

Over 1 Month

1.88%

down

Over 1 Year

-34.82%

down

Over 3 Months

-5.64%

down

Over 3 Years

-5.40%

down

Over 6 Months

-3.53%

down

Over 5 Years

10.41%

down

ZENOTECH LABORATORIES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ZENOTECH LABORATORIES LTD. Share Price

Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f. August 9, 2004. Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables. Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology.

During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd.

M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006.

In 2005-06, M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited got merged with the Company and the Scheme of Amalgamation became effective from October 1, 2005.

Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL on March 24, 2015, SPIL indirectly acquired 46.84 percent of the voting rights held by Ranbaxy in, and control over the Company and became Promoter of the Company along with Daiichi Sankyo Company Limited and resultant, the Open Offer concluded in August 2015.

The Company started production from its newly commissioned Depot Injectable facility in FY 2019-20. It renovated Biotech API manufacturing facility and the same was leased to Sun Pharmaceutical Industries Limited, for their R&D activities effective from July, 2021.

Parent organization Sun Pharma
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zenotech Laboratories Ltd?

Answer Field

Zenotech Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 51.08 as on Nov 03 2025 03:29 PM.

What is the Market Cap of Zenotech Laboratories Ltd Share?

Answer Field

The market cap of Zenotech Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 311.70 as on Nov 03 2025 03:29 PM.

What is the 52 Week High and Low of Zenotech Laboratories Ltd?

Answer Field

The 52 Week High and Low of Zenotech Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 90.00 and ₹ 48.00.

What is 1 year return for Zenotech Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -34.82%.

What is the P/E Ratio of Zenotech Laboratories Ltd Share?

Answer Field

As on Nov 03 2025 03:29 PM the price-to-earnings (PE) ratio for Zenotech Laboratories Ltd share is 62.20.

What is the PB ratio of Zenotech Laboratories Ltd Share?

Answer Field

As on Nov 03 2025 03:29 PM, the price-to-book (PB) ratio for Zenotech Laboratories Ltd share is 15.75.

How to Buy Zenotech Laboratories Ltd Share?

Answer Field

You can trade in Zenotech Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenotech Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenotech Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenotech Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59